Plexaa

Plexaa, founded in 2020, has developed the BLOOM⁴³ platform, the world's first integrated Prehab™ solution for breast surgery. The platform consists of a free smartphone app providing an 8-week pre- and post-surgery program and a Class II FDA-registered medical device that gently heats breast skin to 43°C pre-surgery to boost blood flow. By addressing both the physical and psychological preparation for surgery, Plexaa aims to reduce complications like skin necrosis, improve patient recovery, and increase healthcare system efficiency. The company is commercializing its device for direct purchase via its app while building partnerships with clinics and surgeons.

Integrated Prehab™ platform combining a smartphone app for patient education, support, and journey management with a wearable medical device that delivers precise thermal supraphysiological preconditioning to prepare tissue for surgery.

The competitive landscape for integrated digital-physical prehabilitation platforms is currently nascent, giving Plexaa a first-mover advantage in its niche. Competition exists in fragmented forms: standalone patient education apps, general wellness platforms, and academic prehab programs. No direct competitor offering a similarly FDA-cleared, home-use thermal preconditioning device combined with a dedicated digital therapeutic app for breast surgery was identified from the provided materials.